Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study
CF imposes a considerable economic burden in Iran, predominantly driven by drug and hospitalization expenses. Direct nonmedical costs and indirect costs also contribute meaningfully. These findings highlight the need for improved access to specialized CF care, enhanced insurance coverage, and stronger support for informal caregivers to alleviate the financial pressure on affected families.
Authors
- Ali Mouseli (ORCID: https://orcid.org/0000-0003-0853-5184)
- Shideh Rafati (ORCID: https://orcid.org/0000-0003-3461-0555)
- Maryam Shirvani Shiri (ORCID: https://orcid.org/0000-0002-8612-5204)
- Fatemeh Noroozian
- Hedayat Salari (ORCID: https://orcid.org/0000-0002-3410-5340)
- Hassan Karami (ORCID: https://orcid.org/0000-0002-1040-1508)
- Fatemeh Asadi (ORCID: https://orcid.org/0000-0003-3860-6895)
- Amin Ghanbarnejad (ORCID: https://orcid.org/0000-0002-6623-4163)
- Ali Alizadeh (ORCID: https://orcid.org/0000-0003-2629-3991)
- Narges Salehi (ORCID: https://orcid.org/0009-0006-4495-8845)
- Mitra Nowrouzpour
Institutions
- Hormozgan University of Medical Sciences (IR)
- Bushehr University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of health economics and outcomes research
- Published
- 2025-09-09
- DOI
- https://doi.org/10.36469/001c.143266
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hormozgan University of Medical Sciences